Clinical trial

Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension

NCT02242812

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Telmisartan Normalized identity: telmisartanView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Metoprolol succinate Normalized identity: metoprolol succinateView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2003-09-01

PhasePHASE4

Conditions

Hypertensionunresolved

Interventions

TelmisartanDRUG · verified · RxNorm: telmisartan

Metoprolol succinateDRUG · verified · RxNorm: metoprolol succinate

PlaceboDRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02242812 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.